STAAR Surgical | STAA - Cash And Equivalent


STAAR Surgical reported $176.16M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 8.52B 1.01B Dec/2025
Bausch Health Companies USD 1.31B 419M Sep/2025
Boston Scientific USD 1.96B 690M Dec/2025
Cerus USD 15.67M 321K Sep/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
Exact Sciences USD 956M 166.96M Dec/2025
Hologic USD 2.17B 208.5M Dec/2025
J&J USD 19.71B 1.48B Dec/2025
Merit Medical Systems USD 446.4M 53.95M Dec/2025
Novartis USD 9.56B 2.9B Sep/2025
OraSure Technologies USD 216.48M 18.1M Sep/2025
Orthofix International USD 62.86M 2.75M Sep/2025
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 176.16M 9.02M Sep/2025
Utah Medical Products USD 84.27M 2.09M Sep/2025